Published in Gut on March 01, 2001
Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol (2006) 2.19
Genetic profiling of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol (2012) 1.14
Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography. J Mol Diagn (2010) 0.95
Focal intrahepatic strictures: a review of diagnosis and management. HPB (Oxford) (2012) 0.91
Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig Dis Sci (2007) 0.87
Molecular diagnosis of pancreatobiliary malignancies in brush cytologies of biliary strictures. Gut (2004) 0.86
Ultrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology. J Mol Diagn (2009) 0.84
Molecular diagnosis of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci (2014) 0.79
[Influence of technical advancements on the management of biliary tract diseases]. Wien Med Wochenschr (2006) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology (1980) 3.57
Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology (1995) 2.44
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut (1996) 2.40
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology (1989) 2.39
Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res (1991) 2.30
Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res (1994) 2.26
Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res (1993) 2.22
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Primary sclerosing cholangitis. N Engl J Med (1995) 1.94
Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg (1988) 1.89
Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78
Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol (1987) 1.73
Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology (1991) 1.73
Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology (1998) 1.57
K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance. J Clin Oncol (1999) 1.53
Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology (1992) 1.51
Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology (1996) 1.43
The risk of pancreatic cancer following pancreatitis: an association due to confounding? Gastroenterology (1997) 1.34
Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology (1995) 1.23
The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc (1989) 1.22
Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology (1998) 1.19
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg (1997) 1.16
Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology (1994) 1.10
Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology (1992) 1.08
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology (1999) 1.05
Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut (1991) 0.97
The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology (1997) 0.97
Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis (1991) 0.96
Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology (1994) 0.95
Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses. Gastroenterology (1996) 0.94
Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg (1989) 0.92
Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology (1996) 0.92
Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology (1997) 0.89
Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging. Radiology (1998) 0.86
Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg (1998) 0.85
Primary sclerosing cholangitis: the emerging role for liver transplantation. Am J Gastroenterol (1990) 0.84
K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut (1996) 0.84
Liver transplantation in a 29-year-old patient with gallbladder carcinoma complicating primary sclerosing cholangitis. Z Gastroenterol (1998) 0.80
Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89
Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet (2000) 2.34
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. Neurology (2012) 2.23
Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors. Cold Spring Harb Symp Quant Biol (2005) 2.18
Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations--experience in five patients. Radiology (1998) 2.12
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa. Gut (1999) 1.97
Asymmetry pays: visual lateralization improves discrimination success in pigeons. Curr Biol (2000) 1.92
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology (1995) 1.88
Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol Biol Cell (2001) 1.85
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology (1998) 1.84
Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy (2006) 1.70
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gastroenterol (1994) 1.69
Autoimmunity and liver disease. Hepatology (1990) 1.65
Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J (2003) 1.64
Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease. Scand J Gastroenterol (2004) 1.60
LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis? Clin Exp Immunol (1979) 1.59
Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology (1990) 1.57
Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology (2001) 1.57
Pulmonary hypertension after splenectomy? Ann Intern Med (1999) 1.55
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology (1996) 1.53
Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology (2000) 1.49
Simulation of abdomen sonography. Evaluation of a new ultrasound simulator. Ultraschall Med (2003) 1.47
ARFI elastography of the spleen is inferior to liver elastography for the detection of portal hypertension. Ultraschall Med (2011) 1.46
Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet (1987) 1.43
NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J Biol Chem (2000) 1.37
Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut (2005) 1.34
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C. J Hepatol (2001) 1.31
Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology (2000) 1.30
Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling. Mol Cell Biol (2004) 1.25
Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis. Hepatology (1992) 1.22
Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma. Eur Radiol (2001) 1.22
Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg (2000) 1.20
In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. Antimicrob Agents Chemother (2001) 1.18
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Z Gastroenterol (2012) 1.17
Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol (1998) 1.17
Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology (1995) 1.13
Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization. J Pathol (2001) 1.12
Detection and characterization of liver membrane autoantibodies in chronic active hepatitis by a solid-phase radioimmunoassay. Clin Exp Immunol (1980) 1.12
Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. Gut (2005) 1.11
Telomere shortening and ageing. Z Gerontol Geriatr (2007) 1.10
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. J Viral Hepat (2013) 1.10
Minilaparoscopy for early diagnosis of cirrhosis: is the endoscopist's eye better than the histopathologist's? Endoscopy (2003) 1.10
Liver transplantation for metastatic neuroendocrine tumors. Ann Surg (1997) 1.09
Ovarian-like stroma in an invasive mucinous cystadenocarcinoma of the pancreas positive for inhibin. A hint concerning its possible histogenesis. Virchows Arch (1998) 1.09
Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer. Gut (2003) 1.09
Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg (2000) 1.06
T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones. Eur J Immunol (1990) 1.03
The liver specific protein: evidence for species-specific and non-species-specific determinants. J Clin Lab Immunol (1980) 1.03
Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunit. Curr Biol (2001) 1.01
Evaluation of endoscopic retrograde cholangiopancreatography under conscious sedation and general anesthesia. Endoscopy (2002) 1.01
Arrhythmias and inhibition of noradrenaline uptake caused by tricyclic antidepressants and chlorpromazine on the isolated perfused rabbit heart. Naunyn Schmiedebergs Arch Pharmacol (1975) 1.01
Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy. Gut (1997) 1.01
Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma. J Hepatol (2001) 1.01
Nephron-sparing surgery in synchronous bilateral Wilms' tumors. J Pediatr Surg (1999) 1.01
Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization. Am J Clin Pathol (2000) 1.00
Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proc Natl Acad Sci U S A (2001) 1.00
Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis. Clin Exp Immunol (1991) 0.99
Does the immune response play a role in the pathogenesis of chronic liver disease? Arch Pathol Lab Med (1988) 0.97
Lipoprotein(a) in cirrhosis. BMJ (1992) 0.96
A rare case of bloody diarrhea: thrombosis of the V. mesenterica inferior following laparoscopic cholecystectomy. Z Gastroenterol (1998) 0.95
Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases. Clin Exp Immunol (1984) 0.95
Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology (1989) 0.94
[Malignant epithelioid hemangioendothelioma of the liver - a very rare tumor in children]. Pathologe (1999) 0.94
Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology (1990) 0.94
p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesis. J Biol Chem (1999) 0.94
Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin Immunol (1999) 0.93
Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma. J Mol Diagn (2001) 0.93
Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol (2001) 0.92
Consequences of different housing conditions on brain morphology in laying hens. J Chem Neuroanat (2008) 0.92
[Eosinophilic gastroenteritis with serosa involvement. A rare differential diagnosis of ascites]. Z Gastroenterol (1992) 0.90
Subtypes of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation. Hepatology (1987) 0.89
2-acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of cyclin E expression. Oncogene (1999) 0.89
Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Clin Chem (2000) 0.89
Clinical relevance of mutations in the precore genome of the hepatitis B virus. Gut (1995) 0.88
Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S- and S-encoded viral surface antigens. Hepatology (1991) 0.88
Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology. Z Gastroenterol (2009) 0.88
Antiglomerular basement membrane antibodies in human sera: detection by a modified micro-ELISA. Clin Immunol Immunopathol (1985) 0.88
Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area. Liver (2000) 0.88
Pseudomyxoma peritonei of appendiceal origin--a report of seven cases and a review of published reports. Eur J Surg (1995) 0.88
Differentiation of multicentric origin from intra-organ metastatic spread of hepatocellular carcinomas by comparative genomic hybridization. J Pathol (2000) 0.87
Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy. J Viral Hepat (2000) 0.87
The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatology (1990) 0.86
Reconstructive surgery for ischemic-type lesions at the bile duct bifurcation after liver transplantation. Ann Surg (1999) 0.86
Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated. Z Gastroenterol (2004) 0.86
Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C. Hepatology (1994) 0.86
Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event. J Hepatol (1995) 0.86
Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest (1991) 0.86
Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients. Br J Clin Pharmacol (1996) 0.85
Percutaneous sonographic gastrostomy: method, indications, and problems. Am J Gastroenterol (1998) 0.85